Feasibility and Effectiveness of Vaccines for COVID-19: An Umbrella Review

• Published in: Archives of academic emergency medicine 2024-09, Vol.13 (1)
• Main Authors: SeyedAhmad SeyedAlinaghi, Amirreza Pashapouryeganeh, Soheil Dehghani, Pegah Mirzapour, Faeze Abbaspour, Fatemeh Afroughi, Payman Rahimzadeh, Morvarid Najafi, Hoomaan Ghasemi, Navid Mozafari, Zahra Soltanali, Esmaeil Mehraeen
• Format: Article
• Language: English
• Subjects: COVID-19; Effectiveness; Feasibility; SARS-CoV-2; Vaccines
• ISSN: 2645-4904
• DOI: 10.22037/aaem.v13i1.2357

Introduction: In January 2020, WHO declared the 2019 Coronavirus Disease (COVID-19) a pandemic. Though COVID-19 vaccines are recommended, ongoing surveillance is crucial due to potential unforeseen events. Evaluation of long-term effectiveness and safety and addressing emerging variants are vital. This study integrates systematic reviews to assess COVID-19 vaccine efficacy, immunogenicity, and safety comprehensively. Methods: This study was an umbrella review study on the feasibility and effectiveness of vaccines for COVID-19. We conducted a comprehensive search in PubMed, Web of Sciences, and Scopus, using MeSH terms and keywords related to COVID-19 vaccines. Inclusion criteria comprised peer-reviewed systematic reviews and meta-analyses in English, focusing on feasibility and effectiveness. Exclusion criteria targeted non-systematic reviews exclusively on vaccine safety and duplicates. Two independent reviewers screened and resolved discrepancies. Data extraction included key details.  Methodological quality was assessed using the ROBIS tool. Data synthesis involves narrative and, if applicable, quantitative synthesis (meta-analysis). Reporting followed PRISMA guidelines. Results: A total of 32 systematic reviews were included in the study, of which 20 also conducted a meta-analysis. The studies investigated in the included reviews ranged from 7 to 74. The included articles were conducted in various countries around the globe. The findings indicated that COVID-19 vaccines are generally safe and effective for individuals with various medical conditions. The overall risk of bias for the included studies was assessed as low risk. Conclusion: The study outcomes indicated that mRNA vaccines exhibit a higher incidence of adverse events but demonstrate greater efficacy.  Conversely, inactivated and protein subunit vaccines are safer but exhibit lower efficiency.  Moreover, the vaccine is considered safe for individuals with specific conditions such as inflammatory bowel disease, solid organ transplant recipients, children, pregnant individuals, and those with hematologic problems. Ultimately, the acceptance of the COVID-19 vaccine among individuals is influenced by various factors, including geographic, socioeconomic, and pandemic-related considerations.